MORTIMER IAN (PRESIDENT & CFO) sold 87.0% of their position (40K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $1.78M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/2/2026ACC: 0001193125-26-001172
Officer· PRESIDENT & CFO
Since Sep 2019
-40K
Net shares
Net seller
$1.78M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
40K acquired · 80K disposed
Non-Derivative Transactions3
Common Shares
Direct
Shares
+40K
Price / share
$7.49
Trade value
$299.60K
% of position
666.7%
1/2/2026
6K→46K
Common Shares
Direct
Shares
−37.94K
Price / share
$44.40
Trade value
$1.68M
% of position
82.5%
1/2/2026
46K→8.06K
Common Shares
Direct
Shares
−2.06K
Price / share
$44.93
Trade value
$92.65K
% of position
25.6%
1/2/2026
8.06K→6K
Total
Net shares
+0.00
Net value
-$1.48M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/2/2026 | M · Option Exercise | +40K | $7.49 | $299.60K | 666.7% | 6K | 46K |
| Common Shares Direct | 1/2/2026 | S · Sale | −37.94K | $44.40 | $1.68M | 82.5% | 46K | 8.06K |
| Common Shares Direct | 1/2/2026 | S · Sale | −2.06K | $44.93 | $92.65K | 25.6% | 8.06K | 6K |
| Total | +0.00 | -$1.48M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
40K shares
Shares
−40K
Strike price
7.49
Held after
0.00
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares40K shares | 1/2/2026 | M · Option Exercise | −40K | 7.49 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned14.30K
Total
14.30K indirect14.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 14.30K | Indirect |
| Total | 14.30K | 14.30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported